Daily News Podcast

Valsartan cancer risk is low

Publish date: July 31, 2018

 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Telemedicine payment expansion?
MDedge Cardiology
Epinephrine for cardiac arrest: Better survival, more brain damage
MDedge Cardiology
Bundle pay plan didn’t save money
MDedge Cardiology
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Cardiology
Is fibromyalgia one disorder – or two?
MDedge Cardiology
Is fish oil’s heart benefit a fish tale?
MDedge Cardiology
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Cardiology
Blood pressure meds cut cognitive impairment risk
MDedge Cardiology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Cardiology
Free skin cancer screening highlights need
MDedge Cardiology